Actuate Therapeutics Inc.
ACTU
Market Cap$145.71M
Close$
$1.03
83.5% downside
Current Fair Value
83.5% downsideOvervalued by 83.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $145.71 Million |
|---|---|
| Enterprise Value | $144.46 Million |
| Dividend Yield | $0 (-%) |
| Earnings per Share | $- |
| Beta | 0 |
| Outstanding Shares | - |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -6.08 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | -0.52 |
Revenue Sources
No data
Insider Trades
ESG Score
No data